Log in
NASDAQ:VKTX

Viking Therapeutics News Headlines

$6.26
-0.17 (-2.64 %)
(As of 12/1/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.25
Now: $6.26
$6.48
50-Day Range
$5.30
MA: $6.01
$6.68
52-Week Range
$3.26
Now: $6.26
$8.87
Volume791,277 shs
Average Volume1.37 million shs
Market Capitalization$456.68 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Viking Therapeutics (NASDAQ VKTX) News Headlines Today

Source:
SourceHeadline
Viking Therapeutics (NASDAQ:VKTX) Upgraded at BidaskClubViking Therapeutics (NASDAQ:VKTX) Upgraded at BidaskClub
marketbeat.com - November 6 at 2:21 AM
Viking Therapeutics (NASDAQ:VKTX) Lifted to Sell at BidaskClubViking Therapeutics (NASDAQ:VKTX) Lifted to Sell at BidaskClub
marketbeat.com - September 19 at 5:14 AM
Chardan Capital Raises Viking Therapeutics (NASDAQ:VKTX) Price Target to $20.00Chardan Capital Raises Viking Therapeutics (NASDAQ:VKTX) Price Target to $20.00
marketbeat.com - August 31 at 7:15 AM
Viking Therapeutics (NASDAQ:VKTX) Receives "Buy" Rating from Raymond JamesViking Therapeutics (NASDAQ:VKTX) Receives "Buy" Rating from Raymond James
marketbeat.com - August 6 at 7:41 AM
Viking Therapeutics: Progressing Steadily, But Concerns RemainViking Therapeutics: Progressing Steadily, But Concerns Remain
seekingalpha.com - November 29 at 8:21 AM
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 5%Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 5%
americanbankingnews.com - November 27 at 7:32 PM
3 Stocks with Jaw-Dropping Growth Potential3 Stocks with Jaw-Dropping Growth Potential
finance.yahoo.com - November 23 at 10:16 AM
Viking Therapeutics to Present at Stifel Healthcare Conference 2020Viking Therapeutics to Present at Stifel Healthcare Conference 2020
finance.yahoo.com - November 10 at 5:26 PM
Viking Therapeutics, Inc. (NASDAQ:VKTX) Expected to Post Earnings of -$0.15 Per ShareViking Therapeutics, Inc. (NASDAQ:VKTX) Expected to Post Earnings of -$0.15 Per Share
americanbankingnews.com - November 9 at 9:14 PM
VKTX: Phase 1 Trial of VK0214 Underway…VKTX: Phase 1 Trial of VK0214 Underway…
finance.yahoo.com - October 30 at 2:05 PM
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call TranscriptViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 11:41 PM
Here's Why We're Not Too Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn SituationHere's Why We're Not Too Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Situation
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics, Inc. to Host Earnings CallViking Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateViking Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - October 28 at 6:40 PM
Viking Therapeutics to Report Financial Results for Third Quarter 2020 on October 28, 2020Viking Therapeutics to Report Financial Results for Third Quarter 2020 on October 28, 2020
finance.yahoo.com - October 21 at 5:49 PM
Viking Therapeutics IncViking Therapeutics Inc
reuters.com - October 20 at 2:56 PM
4 Sectors Moving Up In Wednesdays After-Market Session4 Sectors Moving Up In Wednesday's After-Market Session
msn.com - September 23 at 6:55 PM
Viking Therapeutics launches early-stage study of candidate for rare nervous system disorderViking Therapeutics launches early-stage study of candidate for rare nervous system disorder
seekingalpha.com - September 9 at 9:33 AM
Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214
finance.yahoo.com - September 9 at 9:33 AM
Buy the Dip in Viking Therapeutics Stock, Says AnalystBuy the Dip in Viking Therapeutics Stock, Says Analyst
finance.yahoo.com - September 1 at 8:04 PM
VKTX: Continued Liver Fat Reductions Four Weeks Following Final Dose of VK2809 in Phase 2 Trial…VKTX: Continued Liver Fat Reductions Four Weeks Following Final Dose of VK2809 in Phase 2 Trial…
finance.yahoo.com - August 31 at 2:00 PM
Viking Therapeutics VK2809 shows durable effect in mid-stage fatty liver studyViking Therapeutics' VK2809 shows durable effect in mid-stage fatty liver study
seekingalpha.com - August 28 at 8:56 AM
Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020
finance.yahoo.com - August 28 at 8:56 AM
Brokers bullish on Viking Therapeutics Inc sharesBrokers bullish on Viking Therapeutics Inc shares
uk.finance.yahoo.com - August 24 at 7:38 AM
Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020
finance.yahoo.com - August 20 at 8:33 AM
Viking Therapeutics: Another Year In ReviewViking Therapeutics: Another Year In Review
seekingalpha.com - August 13 at 4:18 PM
Did Hedge Funds Make The Right Call On Viking Therapeutics, Inc. (VKTX)Did Hedge Funds Make The Right Call On Viking Therapeutics, Inc. (VKTX)
finance.yahoo.com - August 11 at 10:41 PM
Did Hedge Funds Make The Right Call On Viking Therapeutics, Inc. (VKTX) ?Did Hedge Funds Make The Right Call On Viking Therapeutics, Inc. (VKTX) ?
finance.yahoo.com - August 11 at 5:40 PM
VKTX: IND Filed for VK0214 in X-ALD; New Data for VK2809 to be Presented at EASL…VKTX: IND Filed for VK0214 in X-ALD; New Data for VK2809 to be Presented at EASL…
finance.yahoo.com - August 6 at 12:30 PM
Viking Therapeutics (VKTX) Q2 2020 Earnings Call TranscriptViking Therapeutics (VKTX) Q2 2020 Earnings Call Transcript
finance.yahoo.com - July 30 at 9:28 AM
Viking Therapeutics, Inc.s (VKTX) CEO Brian Lian on Q2 2020 Results - Earnings Call TranscriptViking Therapeutics, Inc.'s (VKTX) CEO Brian Lian on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - July 29 at 11:55 PM
Viking Therapeutics EPS beats by $0.01Viking Therapeutics EPS beats by $0.01
seekingalpha.com - July 29 at 6:54 PM
Viking Therapeutics to Report Financial Results for Second Quarter 2020 on July 29, 2020Viking Therapeutics to Report Financial Results for Second Quarter 2020 on July 29, 2020
finance.yahoo.com - July 22 at 7:59 PM
Should You Buy Viking Therapeutics, Inc. (VKTX)?Should You Buy Viking Therapeutics, Inc. (VKTX)?
finance.yahoo.com - June 24 at 2:12 PM
Many Ifs Surrounding Viking TherapeuticsMany 'Ifs' Surrounding Viking Therapeutics
finance.yahoo.com - June 15 at 6:45 PM
VKTX Viking Therapeutics, Inc. Common StockVKTX Viking Therapeutics, Inc. Common Stock
www.nasdaq.com - May 15 at 7:47 PM
Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual MeetingViking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting
finance.yahoo.com - May 12 at 8:44 PM
Why Viking Therapeutics Is Trading Higher TodayWhy Viking Therapeutics Is Trading Higher Today
www.benzinga.com - May 5 at 4:47 PM
VKTX: Slight Delay in Enrollment in Phase 2b NASH Trial Due to Ongoing Pandemic…VKTX: Slight Delay in Enrollment in Phase 2b NASH Trial Due to Ongoing Pandemic…
finance.yahoo.com - May 5 at 11:45 AM
3 “Strong Buy” Biotech Stocks Trading Under $103 “Strong Buy” Biotech Stocks Trading Under $10
finance.yahoo.com - May 4 at 3:34 PM
Viking Therapeutics Inc (VKTX) Q1 2020 Earnings Call TranscriptViking Therapeutics Inc (VKTX) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 1 at 6:24 PM
Guggenheim likes Seattle Genetics in premarket analyst actionGuggenheim likes Seattle Genetics in premarket analyst action
seekingalpha.com - May 1 at 7:50 AM
Edited Transcript of VKTX earnings conference call or presentation 30-Apr-20 8:30pm GMTEdited Transcript of VKTX earnings conference call or presentation 30-Apr-20 8:30pm GMT
finance.yahoo.com - May 1 at 7:49 AM
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q1 2020 Results - Earnings Call TranscriptViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 2:49 AM
Viking Therapeutics EPS misses by $0.01Viking Therapeutics EPS misses by $0.01
seekingalpha.com - April 30 at 4:48 PM
Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate UpdateViking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
www.prnewswire.com - April 30 at 4:48 PM
Viking Therapeutics to Report Financial Results for First Quarter 2020 on April 30, 2020Viking Therapeutics to Report Financial Results for First Quarter 2020 on April 30, 2020
finance.yahoo.com - April 23 at 8:29 AM
Heres Why Viking Therapeutics Tumbled 20.9% in MarchHere's Why Viking Therapeutics Tumbled 20.9% in March
www.msn.com - April 9 at 10:39 PM
Viking Therapeutics to Participate in 19th Annual Needham Healthcare ConferenceViking Therapeutics to Participate in 19th Annual Needham Healthcare Conference
finance.yahoo.com - April 7 at 4:33 PM
Viking Therapeutics (NASDAQ:VKTX) Is In A Good Position To Deliver On Growth PlansViking Therapeutics (NASDAQ:VKTX) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - March 23 at 9:25 AM
Flipping The Script On Viking TherapeuticsFlipping The Script On Viking Therapeutics
seekingalpha.com - March 18 at 5:33 PM
Viking Therapeutics to buy back $50M of stockViking Therapeutics to buy back $50M of stock
seekingalpha.com - March 17 at 7:51 PM
VKTX: Podium Presentation at EASL…VKTX: Podium Presentation at EASL…
finance.yahoo.com - February 28 at 2:29 PM
Edited Transcript of VKTX earnings conference call or presentation 26-Feb-20 9:30pm GMTEdited Transcript of VKTX earnings conference call or presentation 26-Feb-20 9:30pm GMT
finance.yahoo.com - February 27 at 7:49 AM
This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.